Use of dopamine in prevention of contrast induced acute renal failure - A randomised study

International Journal of Cardiology

Volumn 53, Issue 3, 1996, Pages 233-236

  Kapoor, Aditya ^a   Sinha, Nakul ^a   Sharma, R K ^a   Shrivastava, S ^a   Radhakrishnan, S ^a   Goel, P K ^a   Bajaj, Rajiv ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Contrast; Dopamine; Nephropathy

Indexed keywords

CREATININE; DOPAMINE; MEGLUMINE DIATRIZOATE; NITROGEN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030007676     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-5273(95)02547-2     Document Type: Article

References (18)

1. Kumar S, Hull JD, Lathi S, Cohen AJ, Pletka PG. Low incidence of renal failure after angiography. Arch Intern Med 1981;141:1268-1270.
2. Taliercio CP, Vlietstra RE, Fisher LD, Burnett JC. Risks for renal dysfunction with cardiac angiography. Ann Intern Med 1986;104:501-504.
3. Davidson CJ, Hlatky M, Morris KG, Fleper K et al. Cardiovascular and renal toxicity of a non ionic radiographic contrast agent after cardiac catheterization: a prospective trial. Ann Intern Med 1989;110:119-124.
4. Moore RD, Stainberg EP, Powe NR, White RI Jr et al. Frequency and determinants of adverse reactions induced by high osmolality contrast media. Radiology 1989;170:727-732.
5. Barrett BJ, Parfrey PS, Yavasour HM, McDonald J et al. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 1992;41:1274-1279.
6. Hill JA, Winniford M, Fossen B, Goldfarb S, Miurphy M, Halpern E. For the Iohexol Cooperative study; nephrotoxicity following cardiac angiography: a randomised double blind multicenter trial to ionic and nonionic contrast media in 1194 patients. Circulation 1991;84-II:333 (Abstr).
7. Schwab SJ, Hlatky MA, Pieper KS, Davidson CJ et al. Contrast nephrotoxicity: a randomised control trial of nonionic and an ionic radiographic contrast agent. New Engl J Med 1989;320:149-153.
8. Porter GA. Contrast associated nephropathy. Am J Cardiol 1989;64:22E-26E.
9. Porter GA, Kloster FE, Bristow JD. Sequential effects of angiography contrast agents on renal and systemic hemodynamics. Am Heart J 1971;81:80-89.
10. Workman RJ, Shaff MI, Jackson RV, Diggs J, Frazer MG, Briscoe C. Relationship of renal hemodynamics and functional changes following intravascular contrast to the renin angiotensin system and renal prostacyclin in the dog. Invest Radiol 1983;18:160-166.
11. Haltas S, Billstorm A, Tejler L. Proteinuria following nephroangiography IX. Chemical and morphological analysis in dogs. Acta Radiol 1981;22:427-433.
12. Gelman LM, Rowe JW, Coggins CH. Effects of an angiographic contrast agent on renal function. Cardiovasc Med 1979;4:313.
13. Gomes AS, Baker JD, Martin Paredero V, Dixon SM, et al. Acute renal dysfunction after major arteriography. Am J Roentgenol 1985;145:1249-1253.
14. Tommaso CL. Contrast induced nephrotoxicity in patients undergoing cardiac catheterization Catheter Cardiovasc Diagn 1994;31:316-321.
15. Neumayer HH, Junge W, Kutner A, Wenning A. Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine. A prospective randomized clinical trial. Nephrol Dial Transplant 1989;4:1030-1036.
16. Hall KA, Wong RW, Hunter GC, Camazime BM et al. Contrast induced nephrotoxicity: the effects of vasodilator therapy. J Surg Res 1992;53:317-320.
17. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material induced renal failure in patients with diabetes mellitus, renal insufficiency or both. New Engl J Med 1989;320:143-149.
18. Schwartz LB, Gewertz BL. The renal response to low dose dopamine. J Surg Res 1988;45:574.